Insulinoma is a rare pancreatic tumor that causes excessive production of insulin, leading to low blood sugar levels. The ICD-10 code for Insulinoma is E16.0, while the corresponding ICD-9 code is 211.7. These codes are used for medical billing and classification purposes to identify and track specific diagnoses. It is important to consult with a healthcare professional for accurate diagnosis and appropriate treatment options.
Insulinoma is a rare pancreatic neuroendocrine tumor that arises from insulin-producing cells in the pancreas. It is characterized by excessive insulin production, leading to hypoglycemia (low blood sugar) and related symptoms. In the International Classification of Diseases, 10th Revision (ICD-10), insulinoma is assigned the code D13.7. This code falls under the category of "Benign neoplasms of other endocrine glands and related structures."
The ICD-10 code D13.7 specifically refers to "Benign neoplasm of other specified endocrine glands and related structures." This code is used to classify benign tumors of endocrine glands other than those specifically listed elsewhere in the ICD-10 coding system. Insulinoma falls under this category as it is a benign tumor originating from the endocrine cells of the pancreas.
In contrast, the corresponding ICD-9 code for insulinoma is 211.7. The ICD-9 code system, which was used prior to the implementation of ICD-10, classified insulinoma under the category of "Benign neoplasm of endocrine glands and related structures." This code was utilized to identify benign tumors of various endocrine glands, including the pancreas.
It is important to note that accurate coding is crucial for medical documentation, billing, and statistical analysis. Healthcare professionals rely on these codes to communicate diagnoses effectively and ensure appropriate reimbursement for services provided. Therefore, understanding the appropriate ICD-10 and ICD-9 codes for insulinoma is essential for healthcare providers, medical coders, and insurance companies.